Form 4 for NTRA Natera, Inc.

Accepted 2025-01-31 00:00:00 ET · period of report 2025-01-29 · accession 0001415889-25-002623 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-01-31	2025-01-29	NTRA	Moshkevich Solomon	Pres, CLINICALDIAGNOSTICS	S - Sale	$165.87	-5,201	135.5K	-4%	-$862.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-01-29	S	D	1,178	$165.87	139,056	D	—	—	(F1) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023.
2	Common	Common Stock	2025-01-29	S	D	3	$167.36	135,483	D	—	—	(F2) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024.
3	Common	Common Stock	2025-01-29	S	D	4,020	$165.87	135,486	D	—	—	(F2) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024.